LAUREN WILLMER: Open Payments
NPI 1316389323 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,396 in 90 payments from 14 companies in 2025. Trend: 2023 $2,033 · 2024 $1,533 · 2025 $1,396
Food & beverage: $1,396
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $326 |
| PFIZER INC. | 17 | $223 |
| ABBVIE INC. | 13 | $173 |
| Amgen Inc. | 14 | $151 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $102 |
| Otsuka America Pharmaceutical, Inc. | 4 | $83 |
| Lilly USA, LLC | 5 | $72 |
| Astellas Pharma US Inc | 3 | $61 |
| Novo Nordisk Inc | 4 | $58 |
| Lundbeck LLC | 3 | $48 |
Products named: NURTEC ODT, BREZTRI, REXULTI, TRINTELLIX, VRAYLAR, FARXIGA, MOUNJARO, AIRSUPRA.
Industry payments across AR — which companies pay providers there.
